Gastric cancer: evidence boosts Helicobacter pylori eradication

Affiliations

¹ Fellowship Training Center, Medical Education Center, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan. hsuzuki.a6@keio.jp.
² Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.

Comment

Hidekazu Suzuki et al. Nat Rev Gastroenterol Hepatol. 2018 Aug.

. 2018 Aug;15(8):458-460.

doi: 10.1038/s41575-018-0023-8.

¹ Fellowship Training Center, Medical Education Center, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan. hsuzuki.a6@keio.jp.
² Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.

No abstract available

Comment on

Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.
Leung WK, Wong IOL, Cheung KS, Yeung KF, Chan EW, Wong AYS, Chen L, Wong ICK, Graham DY. Leung WK, et al. Gastroenterology. 2018 Jul;155(1):67-75. doi: 10.1053/j.gastro.2018.03.028. Epub 2018 Mar 14. Gastroenterology. 2018. PMID: 29550592
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.
Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH. Choi IJ, et al. N Engl J Med. 2018 Mar 22;378(12):1085-1095. doi: 10.1056/NEJMoa1708423. N Engl J Med. 2018. PMID: 29562147 Clinical Trial.